Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Lee Claggett

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
JAMA Cardiology|August 9, 2023
Use the Receiver Operating Characteristic to Assess Model Accuracy-ReplyXuan Wang, Brian Lee Claggett, Lu Tian
American Journal of Hypertension|December 12, 2017
Spironolactone and Resistant Hypertension in Heart Failure With Preserved Ejection FractionPatrick Rossignol, Brian Lee Claggett, Jiankang Liu, et al.
Statistics in Medicine|November 16, 2021
Choosing clinically interpretable summary measures and robust analytic procedures for quantifying the treatment difference in comparative clinical studiesZachary R McCaw, Lu Tian, Jiawei Wei, et al.
JAMA Cardiology|February 1, 2023
Quantifying and Interpreting the Prediction Accuracy of Models for the Time of a Cardiovascular Event-Moving Beyond C Statistic: A ReviewXuan Wang, Brian Lee Claggett, Lu Tian, et al.
JAMA Cardiology|December 1, 2021
Practical Recommendations on Quantifying and Interpreting Treatment Effects in the Presence of Terminal Competing Risks: A ReviewZachary R McCaw, Brian Lee Claggett, Lu Tian, et al.
JAMA Network Open|September 15, 2022
Subclinical Risk Factors for Heart Failure With Preserved and Reduced Ejection Fraction Among Black AdultsLi Zhao, Rani Zierath, Jenine E John, et al.
NEJM Evidence|August 30, 2023
Quantifying Treatment Effects in Trials with Multiple Event-Time OutcomesBrian Lee Claggett, Zachary R McCaw, Lu Tian, et al.
JACC. Advances|June 28, 2024
Medical Therapies to Improve Left Ventricular Outflow Obstruction and Diastolic Function in Hypertrophic CardiomyopathyMason Zhu, Klevin Roger L Reyes, Gizem Bilgili, et al.
European Heart Journal. Cardiovascular Imaging|April 20, 2023
Link between myocardial deformation phenotyping using longitudinal and circumferential strain and risk of incident heart failure and cardiovascular deathKristoffer Grundtvig Skaarup, Mats Christian Højbjerg Lassen, Niklas Dyrby Johansen, et al.
International Journal of Cardiology|November 11, 2018
The 3A3B score: The simple risk score for heart failure with preserved ejection fraction - A report from the CHART-2 StudyShintaro Kasahara, Yasuhiko Sakata, Kotaro Nochioka, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
JAMA Cardiology|August 9, 2023
Use the Receiver Operating Characteristic to Assess Model Accuracy-ReplyXuan Wang, Brian Lee Claggett, Lu Tian
American Journal of Hypertension|December 12, 2017
Spironolactone and Resistant Hypertension in Heart Failure With Preserved Ejection FractionPatrick Rossignol, Brian Lee Claggett, Jiankang Liu, et al.
Statistics in Medicine|November 16, 2021
Choosing clinically interpretable summary measures and robust analytic procedures for quantifying the treatment difference in comparative clinical studiesZachary R McCaw, Lu Tian, Jiawei Wei, et al.
JAMA Cardiology|February 1, 2023
Quantifying and Interpreting the Prediction Accuracy of Models for the Time of a Cardiovascular Event-Moving Beyond C Statistic: A ReviewXuan Wang, Brian Lee Claggett, Lu Tian, et al.
JAMA Cardiology|December 1, 2021
Practical Recommendations on Quantifying and Interpreting Treatment Effects in the Presence of Terminal Competing Risks: A ReviewZachary R McCaw, Brian Lee Claggett, Lu Tian, et al.
JAMA Network Open|September 15, 2022
Subclinical Risk Factors for Heart Failure With Preserved and Reduced Ejection Fraction Among Black AdultsLi Zhao, Rani Zierath, Jenine E John, et al.
NEJM Evidence|August 30, 2023
Quantifying Treatment Effects in Trials with Multiple Event-Time OutcomesBrian Lee Claggett, Zachary R McCaw, Lu Tian, et al.
JACC. Advances|June 28, 2024
Medical Therapies to Improve Left Ventricular Outflow Obstruction and Diastolic Function in Hypertrophic CardiomyopathyMason Zhu, Klevin Roger L Reyes, Gizem Bilgili, et al.
European Heart Journal. Cardiovascular Imaging|April 20, 2023
Link between myocardial deformation phenotyping using longitudinal and circumferential strain and risk of incident heart failure and cardiovascular deathKristoffer Grundtvig Skaarup, Mats Christian Højbjerg Lassen, Niklas Dyrby Johansen, et al.
International Journal of Cardiology|November 11, 2018
The 3A3B score: The simple risk score for heart failure with preserved ejection fraction - A report from the CHART-2 StudyShintaro Kasahara, Yasuhiko Sakata, Kotaro Nochioka, et al.
Pageof 2